Duopharma Biotech Bhd (7148) - Total Assets

Latest as of March 2026: RM1.45 Billion MYR ≈ $363.16 Million USD

Based on the latest financial reports, Duopharma Biotech Bhd (7148) holds total assets worth RM1.45 Billion MYR (≈ $363.16 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Duopharma Biotech Bhd - Total Assets Trend (2006–2025)

This chart illustrates how Duopharma Biotech Bhd's total assets have evolved over time, based on quarterly financial data. Also see 7148 market cap overview for the company's overall valuation and market capitalisation.

Duopharma Biotech Bhd - Asset Composition Analysis

Current Asset Composition (December 2025)

Duopharma Biotech Bhd's total assets of RM1.45 Billion consist of 56.6% current assets and 43.4% non-current assets. Review 7148 total liabilities to assess the company's total debt and financial obligations.

Asset Category	Amount (MYR)	% of Total Assets
Cash & Equivalents	RM0.00	20.1%
Accounts Receivable	RM235.37 Million	16.3%
Inventory	RM293.17 Million	20.2%
Property, Plant & Equipment	RM0.00	0.0%
Intangible Assets	RM36.88 Million	2.6%
Goodwill	RM0.00	0.0%

Asset Composition Trend (2006–2025)

This chart illustrates how Duopharma Biotech Bhd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See Duopharma Biotech Bhd (7148) share price today for real-time trading data and today's change.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Duopharma Biotech Bhd's current assets represent 56.6% of total assets in 2025, a decrease from 64.9% in 2006.
Cash Position: Cash and equivalents constituted 20.1% of total assets in 2025, down from 34.2% in 2006.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, an increase from 0.0% in 2006.
Asset Diversification: The largest asset category is inventory at 20.2% of total assets.

Duopharma Biotech Bhd Competitors by Total Assets

Key competitors of Duopharma Biotech Bhd based on total assets are shown below.

Company	Country	Total Assets
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Germany	€1.60 Trillion
GALDERMA GROUP AG NYSE:GALDY	USA	$13.39 Billion
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	USA	$15.42 Trillion
Beijing Tongrentang Co Ltd SHG:600085	China	CN¥31.82 Billion
Takeda Pharmaceutical Company Limited F:TKDA	Germany	€15.41 Trillion
Changchun High & New Technology Industries Group Inc SHE:000661	China	CN¥30.77 Billion
Neuland Laboratories Limited NSE:NEULANDLAB	India	Rs29.30 Billion
China Resources Double-Crane Pharmaceutical Co Ltd SHG:600062	China	CN¥17.01 Billion

Duopharma Biotech Bhd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	2.62	3.83	2.33
Quick Ratio	1.68	2.60	1.39
Cash Ratio	0.00	1.31	0.56
Working Capital	RM510.30 Million	RM561.75 Million	RM262.08 Million

Duopharma Biotech Bhd - Advanced Valuation Insights

This section examines the relationship between Duopharma Biotech Bhd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	1.56
Latest Market Cap to Assets Ratio	0.20
Asset Growth Rate (YoY)	5.2%
Total Assets	RM1.45 Billion
Market Capitalization	$284.98 Million USD

Valuation Analysis

Below Book Valuation: The market values Duopharma Biotech Bhd's assets below their book value (0.20x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: Duopharma Biotech Bhd's assets grew by 5.2% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Duopharma Biotech Bhd (2006–2025)

The table below shows the annual total assets of Duopharma Biotech Bhd from 2006 to 2025.

Year	Total Assets	Change
2025-12-31	RM1.45 Billion ≈ $363.62 Million	+5.18%
2024-12-31	RM1.38 Billion ≈ $345.72 Million	+2.37%
2023-12-31	RM1.35 Billion ≈ $337.72 Million	+10.08%
2022-12-31	RM1.22 Billion ≈ $306.78 Million	+4.96%
2021-12-31	RM1.16 Billion ≈ $292.27 Million	+9.99%
2020-12-31	RM1.06 Billion ≈ $265.74 Million	+15.07%
2019-12-31	RM919.80 Million ≈ $230.93 Million	+9.97%
2018-12-31	RM836.38 Million ≈ $209.99 Million	+18.59%
2017-12-31	RM705.24 Million ≈ $177.06 Million	+6.62%
2016-12-31	RM661.46 Million ≈ $166.07 Million	+4.42%
2015-12-31	RM633.45 Million ≈ $159.04 Million	+184.72%
2014-12-31	RM222.48 Million ≈ $55.86 Million	+8.18%
2013-12-31	RM205.65 Million ≈ $51.63 Million	+3.85%
2012-12-31	RM198.03 Million ≈ $49.72 Million	+0.26%
2011-12-31	RM197.52 Million ≈ $49.59 Million	+0.53%
2010-12-31	RM196.48 Million ≈ $49.33 Million	+13.33%
2009-12-31	RM173.36 Million ≈ $43.53 Million	+15.28%
2008-12-31	RM150.38 Million ≈ $37.76 Million	+18.10%
2007-12-31	RM127.33 Million ≈ $31.97 Million	-19.92%
2006-12-31	RM159.01 Million ≈ $39.92 Million	--

About Duopharma Biotech Bhd

KLSE:7148 Malaysia Drug Manufacturers - Specialty & Generic

Market Cap

$284.98 Million

RM1.14 Billion MYR

Market Cap Rank

#15130 Global

#177 in Malaysia

Share Price

RM1.18

Change (1 day)

-1.67%

52-Week Range

RM1.18 - RM1.55

All Time High

RM2.86